Importer of Controlled Substances Application: Siegfried USA, LLC, 9540 [2021-02974]
Download as PDF
<![CDATA[
9540
Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled substance
Amphetamine ...............
Methamphetamine ........
Drug
code
Schedule
1100
1105
II
II
The company plans to use the listed
controlled substances to develop
manufacturing processes, and conduct
analytical and stability testing. The
company has demonstrated and
received patent numbers U.S. 9,278,904
and U.S. 9,321,794 from the U.S. Patent
Office for the synthesis process for
amphetamines.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–02973 Filed 2–12–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–783]
Importer of Controlled Substances
Application: Siegfried USA, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Siegfried USA, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 18, 2021. Such persons
may also file a written request for a
hearing on the application on or before
March 18, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:04 Feb 12, 2021
Jkt 253001
In
accordance with 21 CFR 1301.34(a), this
is notice that on January 6, 2021,
Siegfried USA, LLC, 33 Industrial Park
Road, Pennsville, New Jersey 08070,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Phenylacetone ..............
Opium, Raw ..................
Poppy Straw Concentrate.
8501
9600
9670
Schedule
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk active pharmaceutical
ingredients (API) for distribution to its
customers. Phenylacetone will be used
to manufacture Amphetamine. No other
activity for this drug code is authorized
for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–02974 Filed 2–12–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
National Institute of Corrections
Advisory Board; Notice of Meeting
This notice announces a forthcoming
meeting of the National Institute of
Corrections (NIC) Advisory Board. At
least one portion of the meeting will be
closed to the public.
Name of the Committee: NIC
Advisory Board.
General Function of the Committee:
To aid the National Institute of
Corrections in developing long-range
plans, advise on program development,
and recommend guidance to assist NIC’s
efforts in the areas of training, technical
assistance, information services, and
policy/program development assistance
to Federal, state, and local corrections
agencies.
Date and Time: 1:00–4:00 p.m. EDT
on Wednesday, March 10, 2021
(approximate time).
Location: Virtual Platform.
Contact Person: Leslie LeMaster,
Executive Assistant, National Institute
of Corrections, 320 First Street NW,
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Room 901–3, Washington, DC 20534. To
contact Ms. LeMaster, please call (303)
338–6620.
Agenda: On March 10, 2021, the
Advisory Board will: (1) Receive a brief
Agency Report from the NIC Acting
Director, (2) provide input and counsel
into an agency decision regarding access
to online training courses hosted by
NIC, and (3) receive a Subcommittee
Report related to the identification of
potential NIC Director candidates. Time
for questions and counsel is built in to
the agenda.
Procedure: On March 10, 2021, from
1:00 p.m. until 3:00 p.m., the meeting is
open to the public. Interested persons
may request to attend virtually, present
data, information, or views, orally or in
writing, on issues pending before the
committee. Such requests must be made
to the contact person on or before
February 26, 2021. Oral presentations
from the public will be scheduled
between approximately 2:45 p.m. to
3:00 p.m. on March 10, 2021. Time
allotted for each presentation may be
limited. Those who wish to make formal
oral presentations should notify the
contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before February 26, 2021.
Closed Committee Deliberations: On
March 10, 2021, between 3:00 p.m. and
4:00 p.m., the meeting will be closed to
permit discussion of information that (1)
relates solely to the internal personnel
rules and practices of an agency (5
U.S.C. 552b(c)(2)), and (2) is of a
personal nature where disclosure would
constitute a clearly unwarranted
invasion of personal privacy (5 U.S.C.
552b(c)(6)). The Advisory Board will
discuss the outcomes of the
subcommittee’s review of potential
candidates for the position of Director of
the National Institute of Corrections and
make determinations as to the Advisory
Board’s recommendations to the U.S.
Attorney General.
General Information: NIC welcomes
the attendance of the public at its
advisory committee meetings and will
make every effort to accommodate
persons with physical disabilities or
special needs. If you require special
accommodations due to a disability,
please contact Leslie LeMaster at least 7
days in advance of the meeting. Notice
of this meeting is given under the
E:\FR\FM\16FEN1.SGM
16FEN1
]]>Agencies
[Federal Register Volume 86, Number 29 (Tuesday, February 16, 2021)]
[Notices]
[Page 9540]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02974]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-783]
Importer of Controlled Substances Application: Siegfried USA, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Siegfried USA, LLC has applied to be registered as an importer
of basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before March 18, 2021.
Such persons may also file a written request for a hearing on the
application on or before March 18, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on January 6, 2021, Siegfried USA, LLC, 33 Industrial
Park Road, Pennsville, New Jersey 08070, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Phenylacetone.......................... 8501 II
Opium, Raw............................. 9600 II
Poppy Straw Concentrate................ 9670 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk active pharmaceutical ingredients (API) for
distribution to its customers. Phenylacetone will be used to
manufacture Amphetamine. No other activity for this drug code is
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-02974 Filed 2-12-21; 8:45 am]
BILLING CODE P
